About

Apr 21-22, 2021    Berlin, Germany

2nd World No Diabetes and Obesity Congress

2nd World No Diabetes  congress cordially invites Researchers,physicians,Doctors associations and Public Healthcare Professionals from all over the globe to be present at "World No Diabetes and Obesity Congress" which is going to be held during April 21-22, 2021 in Berlin, Germany. 2nd World NO Diabetes congress is mainly focusing on “Getting the basics directly in conveying diabetes treatment and care!” to enhance and explore knowledge among the Medical community and to establish corporations and exchanging ideas.

The scientific program has a lot to offer the different subspecialties in our discipline and also covers general topics which will be of interest to many. It is an occasion for participants to come and learn about new developments in the field of Diabetes & Obesity and also an opportunity to share aspects of your own work by submitting a poster or oral presentation. The meeting will provide an opportunity for networking with colleagues and catching up with old acquaintances.

2nd World No Diabetes congress provides two days robust discussions on methods and strategies related to diagnosis, prevention and management of endocrinal diseases as well as explore new ideas and concepts on a global scale and the topics include Diabetic Disorders and Treatment, Current Advances in Endocrinology & Metabolism, Thyroid Gland and its Disorders, Reproductive Endocrinology, Energy Balance and Obesity. The conference invites Endocrine surgeons, Reproductive Endocrinologists and all the eminent researchers and experts in the field of Endocrinal medicine. The conference also welcomes the participation of Presidents, CEO’s, Delegates and industrial executives from Endocrine Pharma and Health care sectors making the conference a perfect platform to network, share views and knowledge through interactive keynote, plenary, poster and B2B discussions.

Sessions/ Tracks:

World No Diabetes 2021 is comprised of various tracks and sessions designed to offer comprehensive sessions that address current issues in the field of Diabetes researches.

Session 1: Endocrinology and Diabetes:

Diabetes is an illness that influences the body's capacity to deliver or utilize insulin. Diabetes is various sicknesses that include issues with the hormone insulin. Regularly, the pancreas discharges insulin to enable the body to store and utilize the sugar and fat from the nourishment that eat. Diabetes happens when the pancreas does not deliver any insulin, when the pancreas creates next to no insulin and when the body does not react suitably to insulin, a condition called insulin opposition.

Session 2: Diabetes & Vascular Diseases:

Heart disease is a complication that may affect people having diabetes if their condition is not managed well for a long period of time. High blood pressure (Hyperglycaemia), which characterizes diabetes, in combination with free fatty acids within the blood can alter the character of blood vessels, and this can lead to heart disease. Vascular disorders include coronary artery disease (CAD), retinopathy (damage to the vision) and nephropathy, peripheral vascular disease (PVD), and heart stroke. Diabetes also affects the heart muscle which causes both systolic and diastolic heart failure.

Session 3: Obesity and Metabolic Disorders:

The metabolic syndrome is a condition categorised by a special constellation of reversible major risk factors for cardiovascular disease and type 2 diabetes. The basic, diagnostic, components are reduced HDL-cholesterol, raised triglycerides, blood pressure and fasting plasma glucose, all of which are related to weight gain, specifically intra-abdominal/ectopic fat accumulation and a large waist circumference. Metabolic syndrome is also promoted by a lack of internal adipose tissue, low skeletal muscle mass and anti-retroviral drugs. Reducing weight by 5–10%, by diet and exercise, with or without, anti-obesity drugs, significantly lowers all metabolic syndrome components, and risk of type 2 diabetes and cardiovascular disease.

Session 4: Non-insulin Therapies:

Despite intensified insulin treatment, many persons with type 1 diabetes (T1D) do not achieve glycemic and metabolic targets. Consequently, non-insulin chemical therapies that improve glycaemic control and metabolic parameters without increasing the risk of adverse events (including hypoglycaemia) are of interest as adjunct therapies to insulin.

Session 5: Advances to treat Diabetes in Pregnancy:

Accomplishing great metabolic control during the period preceding origination is the way to diminishing intrinsic contortions that can happen in pregnancies confounded by diabetes. Different diverse glycatedhemoglobin (HbA1c) levels (the best quality level for learning metabolic control in diabetes) and glucose levels have been suggested. The present rules and most recent investigations on the best levels to get in diabetic ladies previously and during pregnancy are accounted for here and examined. At long last, the ideal helpful methodology and the conceivable beneļ¬ts and dangers identified with the utilization of the new insulin analogues in pregnancy will be investigated.

Session 6: Diabetic Nutrition and Physical Fitness :

Nourishment and physical movement are significant pieces of a sound way of life when you have diabetes. Alongside different advantages, following a solid feast plan and being dynamic can assist you with keeping your blood glucose level, additionally called glucose, in your objective range. To deal with your blood glucose, you have to adjust what you eat and drink with physical movement and diabetes prescription, on the off chance that you take any. What you decide to eat, the amount you eat, and when you eat is terrifically significant in keeping your blood glucose level in the range that your social insurance group prescribes. Getting increasingly dynamic and causing changes in what you to eat and drink can appear to be trying from the outset. You may think that its simpler to begin with little changes and find support from your family, companions, and medicinal services group.

Session 7: Genetics of Diabetes :

Diabetes constitutes a major public health problem. Although substantial progress has been made in defining the genetic risk for specific subtypes of diabetes (e.g., maturity-onset diabetes of the young), the majority of genetic risk of diabetes (for type 1 and type 2) remain unresolved. This review focuses on the current knowledge of the genetic basis of diabetes and its complications, specifically diabetic nephropathy (DN). Ultimately, identification of genes that contribute to risk (or protection) of diabetes and its complications will allow identification of patients who have diabetes and are at risk and targeted treatment/interventional strategies.

Session 8: Diabetes Research in Clinical Practice:

Diabetes research and Novel remedial targets accessible for diabetes incorporates Incretion based treatments, oral helpful operators like secretagogues, cell recovery and growth and foundational organism treatments. Embryonic undeveloped cell and foetal antecedent cell transplantation treatments are the significant undifferentiated cell treatments accessible for Diabetes. Aside from the on high of, completely different procedure methodologies in diabetes administration management are given as these days that square measure presumptuous an essential half in recognizable proof of qualities bringing about diabetes helping in Early Detection of Diabetes.

Session 9: Obesity and Cancer:

Extra fat in the body might have harmful effects, like producing hormones and growth factors that have an effect on the way our cells work. Fat cells also can attract immune cells to body tissues which release chemicals that cause long-lasting inflammation. This can raise the chance of many diseases as well as cancer. People with obesity have chronic low-level or sub-acute unresolved inflammation, which is associated with increased cancer risk. One of the strongest links between obesity and cancer is an increased risk of breast and uterus cancers in ladies who are obese after the menopause, and this relates to higher estrogen levels. Overweight people usually have enlarged levels of hormone and insulin-like growth factor-1 which can result in the development of certain tumors.

Session 10:  Obesity and Weight Management:

Weight management could be a long-run approach to a healthy manner. It includes a balance of healthy consumption and exercise to equate energy expenditure and energy intake. Developing healthy consumption habits while using tips that may keep us fuller longer can be helpful tools in weight management. Knowing what your body desires is very important to weight management and may control overconsumption and under consumption of food. Weight management doesn't include fad diets that promote fast, temporary weight loss. It focuses on the long-term results that are achieved through slow weight loss, followed by retention of an ideal weight for age, sex and height.

Session 11: Prevention of Obesity:

Preventing obesity is important. Once fat cells form, they remain in your body forever. Although you can reduce the size of fat cells, you cannot get rid of them. Obesity experts recommend that a key to preventing excess weight gain is monitoring fat consumption instead of counting calories, and therefore the National cholesterol Education Program maintains that only 30 % of calories should be derived from fat. Because most people eat more than they think they do, keeping a detailed food diary is a useful way to assess eating habits.

Session 12: Current Research on Obesity:

Worldwide, at least 2.8 million people die annually as a results of being overweight or fat, and an estimated 35.8 million (2.3%) of world DALYs are caused by overweight or obesity. Overweight and fatness result in adverse metabolic effects on blood pressure, sterol, triglycerides and hypoglycemic agent resistance. Risks of coronary heart disease, cerebrovascular accident and type 2 diabetes increase steady with increasing body mass index (BMI), a measure of weight relative to height. Raised body mass index also will increase the chance of cancer of the breast, colon, prostate, mucous membrane, excretory organ and gall bladder. Mortality rates increase with increasing overweight, as degrees of measured by body mass index. The prevalence of overweight and fatness were highest within the WHO Regions of the Americas (62% for overweight in each sexes, and twenty sixth for obesity) and lowest within the WHO Region for South East Asia (14% overweight in both sexes and three for obesity).

Session 13: Childhood Obesity and Effects:

Childhood obesity is a serious therapeutic condition that is affecting children and adolescents.  Children at or above the 95th percentile have obesity.  Many obese children become obese adults, especially if one or both parents are obese. The early physical impacts of obesity in adolescence incorporate, the greater part of the child’s organs being influenced, hepatitis, sleep apnoea, gallstones and increased intracranial pressure.Childhood obesity can also result in severe conditions including diabetes, high blood pressure, heart disease, sleep problems, cancer, and other disorders like liver disease, early puberty or menarche, eating disorders such as anorexia and bulimia, skin infections, and asthma and other respiratory problems. 

Session 14: Obesity during Pregnancy:

Obesity in pregnancy can affect health later in life for both mother and child. Gaining too much weight during pregnancy or being overweight or obese, is also risky. Obesity during pregnancy increases the risk of various pregnancy complications, Such as Gestational diabetes, Preeclampsia, Infection, and Pregnancy Loss. Children born to overweight or obese mothers have higher rates of childhood obesity and childhood metabolic syndrome. Losing weight before you become pregnant is the best way to decrease the risk of problems caused by obesity.

Session 15: Clinical Endocrinology & specialized topics in Clinical Endocrinology:

Clinical endocrinology deals with the study of the endocrine system its function, diseases and abnormalities related to a patient. The endocrine system is defined that the organs in the body which further release hormones that use to regulate many of the body’s functions, like testes & ovaries, pancreas, the pituitary gland, and thyroid gland. The individuals which are specialized in clinical endocrinology are highly trained physicians. Extra Specialized topics, on which clinical endocrinology concentrates, like thyroid disorders, hormone disorders of various types can be treated by endocrinologists.

Who Can Attend? 

  • Professors
  • Ph.D. Scholars and Graduates
  • Directors and CEO’s of Organizations
  • Deans and Head of Departments
  • Genomics societies and associations
  • Business Delegates, Sponsors and Exhibitors
  •  
  • Mode of Participations:
  • Speaker
    Delegate
    Workshops
    Poster
    Symposiums
    Exhibitors Booth and Stalls
    Sponsorship
    E-Video Presentation
    Delegate
    Workshops
    Poster
    Symposiums
    Exhibitors Booth and Stalls
    Sponsorship
    E-Video Presentation

Awards:
Best Keynote Speaker Award
Model Organizing Committee Award
Women Scholars
Outstanding Speaker Award
Promising Young Researcher Award
Educative Poster Award

 

  [email protected]
  [email protected]
  [email protected]